肝癌氩氦刀治疗效果评价展望  

Treatment effectiveness evaluation of argon - helium cryoablation in liver cancer

作　　者：高金生(综述)[1] 陆海波(审校)[1] 

机构地区：[1]哈尔滨医科大学附属第三医院内八科,哈尔滨150081

出　　处：《实用肿瘤学杂志》2013年第1期74-76,共3页Practical Oncology Journal

基　　金：黑龙江省自然科学基金（D2007-57）;哈尔滨市科技创新基金（RC2009QN004156）

摘　　要：随着肝癌发生机制研究的深入及肿瘤治疗技术的进步，对肝癌的治疗也有了一定的进展。近年来，氩氦刀治疗肝癌作为一种新的治疗方法，在临床上逐渐得到推广应用。然而肝癌氩氦刀治疗后，如何经济又实用的判断其治疗疗效，一直是困扰临床应用的实际问题。本文拟就国内外相关研究进展进行探讨。As the evolutions of pathogenesis and oncotherapy on oncology, great progression has been made in treating with primary hepatocellular carcinoma （ HCC ）. Recent years, argon - helium cryoablation, which is a new therapeutic method, has been extensivly used in clinical. However, after treating primary hepatocellular carcinoma by argon - helium cryoablation, how to evaluate effectiveness economically and practically is still a puzzle in clinical applicationl In this review, we will approach the related research from home and aboard.

关 键 词：肝癌 氩氦刀 疗效评价 

分 类 号：R735.7[医药卫生—肿瘤]